Amalgamated Bank’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Hold |
2,912
| – | – | ﹤0.01% | 2908 |
|
|
2025
Q1 | $2K | Hold |
2,912
| – | – | ﹤0.01% | 2836 |
|
|
2024
Q4 | $5K | Hold |
2,912
| – | – | ﹤0.01% | 2718 |
|
|
2024
Q3 | $10K | Hold |
2,912
| – | – | ﹤0.01% | 2444 |
|
|
2024
Q2 | $10K | Hold |
2,912
| – | – | ﹤0.01% | 2432 |
|
|
2024
Q1 | $21K | Sell |
2,912
-4,535
| -61% | -$32.7K | ﹤0.01% | 2102 |
|
|
2023
Q4 | $28K | Sell |
7,447
-867
| -10% | -$3.26K | ﹤0.01% | 2496 |
|
|
2023
Q3 | $18K | Hold |
8,314
| – | – | ﹤0.01% | 2702 |
|
|
2023
Q2 | $40K | Sell |
8,314
-3,320
| -29% | -$16K | ﹤0.01% | 2413 |
|
|
2023
Q1 | $66K | Sell |
11,634
-1,744
| -13% | -$9.89K | ﹤0.01% | 2191 |
|
|
2022
Q4 | $135K | Hold |
13,378
| – | – | ﹤0.01% | 2010 |
|
|
2022
Q3 | $300K | Buy |
13,378
+215
| +2% | +$4.82K | ﹤0.01% | 1674 |
|
|
2022
Q2 | $326K | Sell |
13,163
-123
| -0.9% | -$3.05K | ﹤0.01% | 1669 |
|
|
2022
Q1 | $515K | Sell |
13,286
-998
| -7% | -$38.7K | ﹤0.01% | 1533 |
|
|
2021
Q4 | $836K | Sell |
14,284
-152
| -1% | -$8.9K | 0.01% | 1333 |
|
|
2021
Q3 | $856K | Sell |
14,436
-705
| -5% | -$41.8K | 0.01% | 1321 |
|
|
2021
Q2 | $1.31M | Buy |
15,141
+4,300
| +40% | +$373K | 0.01% | 1151 |
|
|
2021
Q1 | $894K | Sell |
10,841
-354
| -3% | -$29.2K | 0.03% | 643 |
|
|
2020
Q4 | $1.02M | Buy |
11,195
+54
| +0.5% | +$4.91K | 0.04% | 523 |
|
|
2020
Q3 | $445K | Buy |
11,141
+1,116
| +11% | +$44.6K | 0.02% | 907 |
|
|
2020
Q2 | $344K | Sell |
10,025
-960
| -9% | -$32.9K | 0.02% | 1032 |
|
|
2020
Q1 | $244K | Sell |
10,985
-668
| -6% | -$14.8K | 0.01% | 1257 |
|
|
2019
Q4 | $228K | Buy |
+11,653
| New | +$228K | ﹤0.01% | 1571 |
|